Quadratus Lumborum Block Versus Caudal Block for Pediatric Postoperative Analgesia

September 5, 2022 updated by: Doaa Lotfy, Fayoum University Hospital

Ultrasound Guided Quadratus Lumborum Block Versus Caudal Block for Pain Relief in Children Undergoing Lower Abdominal Surgeries

The aim of this study is to compare between two regional analgesic techniques; caudal block and ultrasound guided quadratus lumborum block as regard degree of pain relief, accuracy of block, effect on hemodynamic stability and incidence of complications.

Study Overview

Detailed Description

Regional anesthesia and analgesia techniques are commonly used during pediatric surgical practice to facilitate pain control, decrease parenteral opioid requirements and improve the quality of post-operative pain control and patient-parent satisfaction. The most commonly used technique is caudal anesthesia, which is generally indicated for urologic surgery, inguinal hernia repair and lower extremity surgery. The quadratus lumborum (QL) block is a recently introduced abdominal truncal block, used for somatic and visceral analgesia of both the upper and lower abdomen. It was first described by Blanco in 2007 . Currently, the QL block is performed as one of the perioperative pain management procedures for all generations (pediatrics, pregnant, and adult) undergoing abdominal surgery . QL block allows the local anesthetics to spread between the posterior aspect of the quadratus lumborum muscle and the medial layer of the thoracolumbar fascia, which is close to the thoracic paravertebral space .

The ultrasound (US) has gained popularity among anesthesiologists performing regional anesthesia. Block success, and hence the efficacy would depend on the patient's anatomical variations and the anesthesiologist's skill level .

The use of ultrasound-guidance for peripheral nerve blocks (PNBs) offers many advantages. Direct visualization of the nervous and surrounding structures decreases the incidence of complications e.g. inadvertent intraneural or intravascular injection. Direct real-time observation of the local anesthetics spread ensures more accurate deposition .This leads to faster onset and longer duration of block, thus improves block quality. It also allows dose reduction of local anesthetics . It has been shown that when peripheral nerves are adequately imaged by ultrasound, the simultaneous use of the nerve stimulator offers no further advantages.

Following ethical committee approval of Anesthesia department, Fayoum University and obtaining informed consent from parents of each patient, fifty two patients will be randomized into 2 study groups. Each group contains 26 patients.

Methodology:

Preoperative Assessment:

All patients will be assessed clinically and investigated for exclusion of any of the above mentioned contraindications.

Operating Room Preparation & Equipment:

The ultrasound used will be Sonosite M Turbo (USA), the scanning probe will be the linear multi-frequency 13-6 MHz transducer (L25x13-6 MHz linear array). The needle used will be the stimuplex D needles manufactured by B Braun (Germany).

Perioperative Management:

All patients will be premedicated with IM midazolam 0.2 mg/kg and atropine 0.02 mg/kg. Perioperative monitoring will include continuous ECG, pulse oximetry, non-invasive arterial blood pressure, and temperature monitoring.

Inhalational induction of general anesthesia (GA) will be performed with a face mask using sevoflurane 8% and 50% oxygen in air, and then an intravenous (IV) cannula will be inserted. Fentanyl will be administered intravenously at 1 μg/kg, and a laryngeal mask airway (Intavent - Orthofix, Maidenhead, United Kingdom) will be used to secure the upper airway, with the patient kept spontaneously breathing. Anesthesia will be maintained with Isoflurane and 50% oxygen in air.

Surgery will be allowed to begin 10 minutes after block application. At the end of surgery, acetaminophen 15 mg/kg IV will be administered to all patients. Any complications occurring during the procedure will be recorded.

After completion of surgical procedure and emergence from anesthesia the patient will be referred to PACU. Quality of analgesia will be assessed using a FLACC scale at 30 minutes and at 1, 2, 4, 6, 12, and 24 hours postoperatively. Diclofenac sodium 1 mg/kg rectally will be given as rescue analgesia for patients in all study groups in PACU if FLACC scale > 4. Parents will be informed about the pain evaluation, and when patients had pain at home, parents will be instructed to give oral paracetamol 30 mg/kg. The anesthesiologist will record data received from the parents over the phone.

Statistical Analysis Sample size was calculated using the G* Power software version 3.1.7 analysis program (Heinirch Heine University, Dusseldorf, Germany) before the study. Depending on previous similar research with calculated effect size (d) 0.85, two tails (two sided), type 1 error 0.05 and increasing power of study to 90%, it was determined that each group should include at least 26 subject to obtain significant statistical value.

Collected data will be computerized and analyzed using statistical package for social science (SPSS) version 16. The results will be expressed as number and percentages for qualitative variables, mean, standard deviation and range for continuous data, median and inter-quartile range for quantitative discrete variables and scores.

To compare between groups, the chi-square will be used for qualitative variables, student t rest for comparing quantitative continuous variables between 2 groups, Mann Whitney U test to compare scores between 2 groups. Probability (P) value of less than 0.05 will be considered statistically significant.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Faiyum Governorate
      • Madīnat al Fayyūm, Faiyum Governorate, Egypt, 63514
        • Fayoum University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 months to 5 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age 1-7 years
  • American Society of Anesthesiologists physical status I-II
  • Lower abdominal surgery

Exclusion Criteria:

  • History of developmental delay or mental retardation
  • Parent refusal
  • History of allergic reactions to local anesthetics
  • Rash or infection at the injection site
  • Anatomical abnormality
  • Bleeding disorders.
  • History of cardiac, neurological, renal, hepatic diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Quadratus Lumborum Block (QL)
Patients will be placed in the lateral position,The high-frequency linear probe will be placed on the lateral abdomen, slightly cephalic to the iliac crest. Once the QL muscle will be observed, the probe will be tilted slightly to the caudal direction, to show the largest slice of the QL muscle, to confirm its posterior aspect. A 22-G block needle (Stimuplex D, Braun, Hongo, Bunkyo-ku, and Tokyo) will be inserted in-plane, ~1 cm ventral to the probe. The needle tip will be advanced until it penetrates the posterior fascia of the QL muscle. A small amount of saline will be injected to confirm the correct position of the tip, between the QL muscle and the erector spinae and latissimus dorsi muscles (Posterior or QL block type 2), then a bolus of 0.5 ml/Kg bupivacaine 0.25% will be injected.
Posterior or QL block type 2 , a bolus of 0.5 ml/Kg bupivacaine 0.25%
Active Comparator: Caudal block (C)
After induction of general anesthesia, a lateral position is obtained with the upper hip flexed 90⁰ and the lower one only 45⁰. A line is drawn to connect the posterior superior iliac spines bilaterally and used as one side of an equilateral triangle; then the location of the sacral hiatus should be approximated. By palpating the sacral cornua as 2 bony prominences, the sacral hiatus could be identified as a dimple in between. A 22 gauge needle is inserted at 45 degrees to the sacrum and redirected if the posterior surface of sacral bone is contacted. Children will receive caudal block with 1 ml/kg of bupivacaine 0.25%.
caudal block with 1 ml/kg of bupivacaine 0.25%.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time at which the first analgesia required
Time Frame: 24 hours after procedure
in hours
24 hours after procedure

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain assessment by the aid of FLACC score
Time Frame: 30 minutes after operation
F:Face ,L:Legs, A:Activity, C:Cry, C:Consolability score
30 minutes after operation
Pain assessment by the aid of FLACC score
Time Frame: 1 hour after operation
F:Face ,L:Legs, A:Activity, C:Cry, C:Consolability score
1 hour after operation
Pain assessment by the aid of FLACC score
Time Frame: 2 hours after operation
F:Face ,L:Legs, A:Activity, C:Cry, C:Consolability score
2 hours after operation
Pain assessment by the aid of FLACC score
Time Frame: 4 hours after operation
F:Face ,L:Legs, A:Activity, C:Cry, C:Consolability score
4 hours after operation
Pain assessment by the aid of FLACC score
Time Frame: 6 hours after operation
F:Face ,L:Legs, A:Activity, C:Cry, C:Consolability score
6 hours after operation
Pain assessment by the aid of FLACC score
Time Frame: 12 hours after operation
F:Face ,L:Legs, A:Activity, C:Cry, C:Consolability score
12 hours after operation
Pain assessment by the aid of FLACC score
Time Frame: 24 hours after operation
F:Face ,L:Legs, A:Activity, C:Cry, C:Consolability score
24 hours after operation
number of analgesic doses for each patient
Time Frame: 24 hours after operation
by oral paracetamol 30 mg/kg given by parents
24 hours after operation
The general satisfaction score of parents
Time Frame: 24 hours after operation
measured on a 5-point scale of 1.Extremely dissatisfied 2.Dissatisfied 3.Not satisfied, nor dissatisfied 4.Satisfied 5.Completely satisfied.
24 hours after operation
Preoperative heart rate
Time Frame: 5 minutes before operation
in beat per minutes measured by electrocardiogram
5 minutes before operation
Preoperative systolic blood pressure
Time Frame: 5 minutes before operation
in mm mercury measured by non-invasive blood pressure measurement
5 minutes before operation
Preoperative diastolic blood pressure
Time Frame: 5 minutes before operation
in mm mercury measured by non-invasive blood pressure measurement
5 minutes before operation
Intraoperative systolic blood pressure
Time Frame: every 15 minutes till end of operation
in mm mercury measured by non-invasive blood pressure measurement
every 15 minutes till end of operation
Intraoperative diastolic blood pressure
Time Frame: every 15 minutes till end of operation
in mm mercury measured by non-invasive blood pressure measurement
every 15 minutes till end of operation
Intraoperative heart rate
Time Frame: every 15 minutes till end of operation
in beat per minutes measured by electrocardiogram
every 15 minutes till end of operation
Incidence of hypotension
Time Frame: within one hour of the intervention
drop of blood pressure more than 20 % of baseline blood pressure
within one hour of the intervention
Incidence of bradycardia
Time Frame: Within one hour of the intervention
Heart rate below 50 beat per minute by electrocardiogram
Within one hour of the intervention
Incidence of vascular puncture
Time Frame: Within one hour of the intervention
as signs of local anesthetics toxicity
Within one hour of the intervention
Incidence of convulsions
Time Frame: Within one hour of the intervention
as signs of local anesthetics toxicity
Within one hour of the intervention
Incidence of arrhythmias
Time Frame: Within one hour of the intervention
as signs of local anesthetics toxicity
Within one hour of the intervention
Incidence of paresthesia
Time Frame: Within one hour of the intervention
as signs of local anesthetics toxicity
Within one hour of the intervention
Incidence of hematoma formation
Time Frame: Within one hour of the intervention
Recorded under ultrasound guidance
Within one hour of the intervention
Incidence of injury to the underlying structures
Time Frame: Within one hour of the intervention
Injury to the liver or a viscous
Within one hour of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Kareem M Nawwar, MD, Kasr ElAini Hospital, Faculty Of Medicine, Cairo Univerisity

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 2, 2019

Primary Completion (Actual)

August 1, 2020

Study Completion (Actual)

October 15, 2020

Study Registration Dates

First Submitted

August 1, 2018

First Submitted That Met QC Criteria

August 23, 2018

First Posted (Actual)

August 24, 2018

Study Record Updates

Last Update Posted (Actual)

September 7, 2022

Last Update Submitted That Met QC Criteria

September 5, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Clinical Trials on Quadratus Lumborum Block

3
Subscribe